INRATIO PT/INR TEST STRIPS
Report
- Report Number
- 2027969-2014-00579
- Event Type
- Injury
- Date Received
- June 16, 2014
- Date of Event
- May 21, 2014
- Report Date
- May 28, 2014
- Manufacturer
- ALERE SAN DIEGO, INC.
- Product Code
- GJS
- PMA / PMN Number
- K092987
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- NURSE
Narratives
INVESTIGATION/CONCLUSION: THE CUSTOMER MISINTERPRETED THE ICONS DISPLAYED ON THE INSTRUMENT. THE USER GUIDE FOR THE INRATIO2 PT/INR MONITOR DISCUSSES THE MEANING OF THE DISPLAYED SYMBOLS FOR TROUBLESHOOTING. NO RESULTS WERE DISPLAYED ON THE SCREEN. RETAIN STRIP TESTING RESULTS MET BOTH ACCURACY AND REPEATABILITY CRITERIA. A REVIEW OF THE BATCH RECORD FOR THE LOT DID NOT UNCOVER ANY NON-CONFORMANCES. THE PRODUCT WAS FOUND TO MEET SPECIFICATIONS AND NO DEFICIENCY WAS ESTABLISHED. BASED ON THE INFO AVAILABLE, THERE IS NO INDICATION OF A PRODUCT DEFICIENCY. NO CORRECTIVE ACTION IS REQUIRED AT THIS TIME. THE ISSUE WILL BE SUBJECT TO TRACKING AND TRENDING.
CUSTOMER REPORTS THAT ON (B)(6) 2014, THEY RECEIVED A MESSAGE OF "HI" DISPLAYED ON THE INSTRUMENT AND HELD THE PT'S COUMADIN AS A RESULT. THE NURSE ORDERED A STAT LABORATORY INR AT THE SAME TIME. THE STAT LABORATORY RESULT WAS 1.6 HOWEVER, IT WAS NOT RECEIVED UNTIL (B)(6) 2014. THE PT'S COUMADIN WAS THEN INCREASED TO 6MG. A RECHECK OF THE INR WAS PERFORMED ON (B)(6) 2014. REPORTEDLY, LOVENOX HAS BEEN USED INTERMITTENTLY FOR TWO (2) WEEKS. THERE WAS NO ADDITIONAL INFO PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 351938 | INRATIO PT/INR TEST STRIPS | PROTHROMBIN TIME TEST | GJS | ALERE SAN DIEGO, INC. | 100139 | 343286 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other | COUMADIN, 6 MG (B)(6) 2014| COUMADIN HELD X 2 DAYS| LOVENOX| INRATIO MONITOR: SN (B)(4)| LOVENOX 60 MG X 4 DAYS| COUMADIN 6 MG| LOVENOX 60 MG (B)(6) 2014| COUMADIN 5 MG| COUMADIN 2 MG, INCREASED TO 4 MG |